New Epigenome Technologies Blog post! bit.ly/4ashyOo
"NSD2 and H3K36me2: Revealing the Basis for Prostate Cancer Cell Lineage Plasticity and Uncovering Therapeutic Strategies"
Based on a Nature article by Chao Lu and Michael M. Shen
#EpigenomeTech #Blog #ProstateCancer #Cancer #NSD2 #H3K36me2
Epigenetics Update - NSD2 targeting reverses plasticity and drug resistance in prostate cancer go.nature.com/4imgShn
Chao Lu and Michael M. Shen (Columbia University) in Nature
#Epigenetics #ProstateCancer #NSD2 #H3K36me2
---
Empower your research with: epigenometech.com
Epigenetics Update – Reprogramming of H3K36me2 guides lineage-specific post-implantation de novo DNA methylation go.nature.com/43jkfzm
#Epigenetics #DNAm #H3K36me2 #Development
---
High-resolution insights without cell sorting; epigenometech.com
Epigenetics Update - Paraspeckle protein NONO regulates active chromatin by allosterically stimulating NSD1 bit.ly/4mRUfmp
Jia-Ray Yu reporting in Cell Rep
#Epigenetics #Chromatin #NSD1 #H3K36me2
---
Gain deeper insights into gene regulation; epigenometech.com
Epigenetics Update - NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers go.nature.com/4mtd2Uj
#Epigenetics #Chromatin #NSD2 #Cancer #H3K36me2
---
Empower your research with high-res epigenetic insights at epigenometech.com
RESEARCH | Y Wang, H Xie, Q Liu, CY Wang et al. (HUST, CN)
#Kdm2a demethylates #H3K36me2 to mediate fast-to-slow-twitch #myofiber transition and reshape #SkeletalMuscle metabolic flexibility under #metabolic stress conditions